Skip to main content

and
  1. No Access

    Chapter

    Pediatric Adaptive Athletes

    There are many benefits of physical activity and sports participation for children and adolescents across the entire range of functional abilities. Youth with disabilities have some unique considerations when ...

    Stephanie Tow, Stephanie Green, Jeremy Shapiro, Mark Fisher in Adaptive Sports Medicine (2023)

  2. Article

    Open Access

    The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours

    Gastrointestinal stromal tumours (GISTs) are the most common gastrointestinal tract mesenchymal tumours. Tyrosine kinase inhibitors (TKIs) have transformed the management of advanced GIST. Imatinib was the fir...

    Tiffany Foo, David Goldstein, Eva Segelov, Jeremy Shapiro in Targeted Oncology (2022)

  3. Article

    Open Access

    A qualitative investigation of the supportive care experiences of people living with pancreatic and oesophagogastric cancer

    Pancreatic and oesophagogastric (OG) cancers have a dismal prognosis and high symptom burden, with supportive care forming an integral component of the care provided to patients. This study aimed to explore th...

    Nadia N. Khan, Ashika Maharaj, Sue Evans, Charles Pilgrim in BMC Health Services Research (2022)

  4. No Access

    Article

    BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?

    B-Raf proto-oncogene (BRAF)-V600E mutations (BRAFmt) in colorectal cancer (CRC) predominantly occur in right-side (RS) primaries. In metastatic CRC (mCRC), there is substantial overlap between the reported fea...

    Vanessa Wong, Margaret Lee, Rachel Wong, Jeanne Tie, Jeremy Shapiro in Targeted Oncology (2021)

  5. No Access

    Article

    Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data

    Simulation models utilizing real-world data have potential to optimize treatment sequencing strategies for specific patient subpopulations, including when conducting clinical trials is not feasible. We aimed t...

    Koen Degeling, Hui-Li Wong, Hendrik Koffijberg, Azim Jalali in PharmacoEconomics (2020)

  6. No Access

    Article

    Is there a social cost of randomization?

    Randomized controlled trials, which randomly allocate benefits to a treatment group and not a control group, ascribe differences in post-treatment welfare to the benefits being allocated. However, it is possib...

    Johannes Haushofer, Michala Iben Riis-Vestergaard in Social Choice and Welfare (2019)

  7. Article

    Open Access

    Timing of palliative care referral and aggressive cancer care toward the end-of-life in pancreatic cancer: a retrospective, single-center observational study

    Pancreatic cancer is noted for its late presentation at diagnosis, limited prognosis and physical and psychosocial symptom burden. This study examined associations between timing of palliative care referral (P...

    Natasha Michael, Greta Beale, Clare O’Callaghan, Adelaide Melia in BMC Palliative Care (2019)

  8. Article

    Open Access

    ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours

    Patients with metastatic colorectal cancer whose disease has progressed on oxaliplatin- and irinotecan-containing regimens may benefit from EGFR-inhibiting monoclonal antibodies if they do not contain mutation...

    Eva Segelov, Paul Waring, Jayesh Desai, Kate Wilson, Val Gebski in BMC Cancer (2016)